Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Takao Kaji"'
Autor:
Katsunori Nonogaki, Takao Kaji
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 14, p 7784 (2024)
Liraglutide, a glucagon-like peptide 1 analog used to treat type 2 diabetes and obesity, is a potential new treatment modality for bile acid (BA) diarrhea. Here, we show that administration of liraglutide significantly decreased total BAs, especially
Externí odkaz:
https://doaj.org/article/fbaa668a32204fec80e521f28802673e
Autor:
Katsunori Nonogaki, Takao Kaji
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Farnesoid X receptor (FXR) and Takeda G protein-coupled Receptor 5 (TGR5), the intestinal bile acid (BA) receptors, regulate the gut-derived hormones including fibroblast growth factor 15/19 (FGF15/19) and serotonin (5-hydrooxytryptamine, 5-HT). Here
Externí odkaz:
https://doaj.org/article/18907a92c5bf4bad87e66f4ff99023e1
Autor:
Katsunori Nonogaki, Takao Kaji
Publikováno v:
Heliyon, Vol 6, Iss 12, Pp e05774- (2020)
Plasma fibroblast growth factor 21 (FGF21) levels and hepatic FGF21, serotonin 2a receptor (htr2a), and stromal cell-derived factor 2 like 1 (Sdf2l1) expression are increased in insulin-resistant C57BL6J mice fed a high-fat diet. Here we show that pl
Externí odkaz:
https://doaj.org/article/be26db61e8d34ca2be453e89f10d570f
Autor:
Katsunori Nonogaki, Takao Kaji
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
A recent report suggested that brain-derived serotonin (5-HT) is critical for maintaining weight loss induced by glucagon-like peptide-1 (GLP-1) receptor activation in rats and that 5-HT2A receptors mediate the feeding suppression and weight loss ind
Externí odkaz:
https://doaj.org/article/f5bb7b12208a44a58e2ab3b5aa8f9f16
Autor:
Katsunori Nonogaki, Takao Kaji
Farnesoid X receptor (FXR), a BA receptor, and fibroblast growth factor 15 (FGF15) regulate enterohepatic circulation of BAs, glucose, and lipid metabolism. Here we show that ingestion of whey protein isolate, a milk protein, significantly increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c3014a0e6a385c97bfa63f5a6408c93
https://doi.org/10.21203/rs.3.rs-1769210/v1
https://doi.org/10.21203/rs.3.rs-1769210/v1
Autor:
Takao Kaji, Katsunori Nonogaki
Publikováno v:
Heliyon, Vol 6, Iss 12, Pp e05774-(2020)
Heliyon
Heliyon
Plasma fibroblast growth factor 21 (FGF21) levels and hepatic FGF21, serotonin 2a receptor (htr2a), and stromal cell-derived factor 2 like 1 (Sdf2l1) expression are increased in insulin-resistant C57BL6J mice fed a high-fat diet. Here we show that pl
Autor:
Katsunori Nonogaki, Takao Kaji
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Insufficient expression of hepatic fibroblast growth factor 21 (FGF21) and stromal cell-derived factor 2 like 1 (Sdf2l1) reportedly leads to insulin resistance and hepatosteatosis in obesity and type 2 diabetes. On the other hand, increased expressio
Autor:
Takao Kaji1,2, Reimer, James D.3, Morov, Arseniy R.1,4, Shigeru Kuratani5, Kinya Yasui1 furaha@sci.hiroshima-u.ac.jp
Publikováno v:
Zoological Letters. 2/6/2016, Vol. 2, p1-14. 14p.
Publikováno v:
Neuropsychiatry.
Background The aim of our study is to determine circulating fibroblast growth factor (FGF21) levels in obese and diabetic db/db mice, and role of serotonin (5-HT) in the regulation of hepatic FGF21 expression and circulating FGF21 levels in relation
Publikováno v:
Neuropsychiatry.
Background: Fibroblast growth factor 21 (FGF21) is primarily secreted by the liver as an endocrine hormone, and circulating FGF21 levels are elevated in mice with diet-induced obesity and an insulin-resistant state. The aim of our study was to determ